Valeant To Hold Conference Call To Present Fourth Quarter And Full Year 2016 Results And Announce 2017 Guidance
LAVAL, Quebec, Jan. 30, 2017 /CNW/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) ("Valeant" or the "Company") today announced that it plans to hold a conference call and live webcast on Tuesday, February 28, 2017 at 8:00 a.m. ET. The Company will discuss fourth quarter and full year 2016 financial results, and announce 2017 guidance during the presentation. Related materials will be made available on the investor relations portion of the corporate website before the start of the conference call.
Conference Call Details
| Date |
Tuesday, February 28, 2017 |
| Time |
8:00 a.m. ET |
| Webcast |
|
| Participant Event Dial-in |
(877) 876-8393 (North America) |
| (443) 961-0178 (International) |
|
| Participant Passcode |
63999208 |
| Replay Dial-in |
(855) 859-2056 (North America) |
| (404) 537-3406 (International) |
|
| Replay Passcode |
63999208 (replay available until 03/31/2017) |
About Valeant
Valeant Pharmaceuticals International, Inc. (NYSE/TSX:VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, gastrointestinal disorders, eye health, neurology and branded generics. More information about Valeant can be found at www.valeant.com.
Contact Information:
Elif McDonald
[email protected]
514-856-3855
877-281-6642 (toll free)
Media:
Renée Soto or
Chris Kittredge/Jared Levy
Sard Verbinnen & Co.
212-687-8080
SOURCE Valeant Pharmaceuticals International, Inc.
To view this news release in HTML formatting, please use the following URL: http://www.newswire.ca/en/releases/archive/January2017/30/c3601.html
Share this article